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Abstract  
 
Background: Due to limited existing data, we investigated health-related quality of life HrQoL in 
Filipino persons undergoing TB treatment, and if it is negatively impacted by co-morbidity with 
undernutrition, diabetes and anaemia. 
 
Methods: Adult participants were enrolled in public facilities in Metro Manila (3 sites) and Negros 
Occidental (2 sites). Multivariate linear regression was used to model the four correlated domain 
scores from the WHOQOL-BREF questionnaire (physical, psychological, social, environmental). A 
forward-stepwise approach was used to select a final multivariable model with inclusion based on 
global tests of significance with p<0.1. 
 
Results: In 446 persons on drug-sensitive TB treatment, diabetes and moderate/severe anaemia 
were not associated with HrQoL. After adjustment for age, sex, education, food insecurity, 
treatment adherence, inflammation, category I or II TB treatment, treatment phase, current side 
effects and inhibited ability to work, moderate/severe undernutrition (BMI<17 kg/m2) was 
associated with lower HrQoL (p=0.003) with reduced psychological (coefficient:-1.02; 95% CI: -1.54, -
0.51), physical (-0.62; -1.14, -0.09) and environmental domain scores (-0.45; -0.88,-0.01). In 225 
patients with known HIV status in Metro Manila, HIV was associated with modestly reduced HrQoL 
(p=0.014).  
 
Conclusions: Nutritional status and food insecurity represent modifiable risk factors for poor HrQoL 
that may be alleviated through interventions.   
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Abstract (Francaise)  
Contexte: En raison de la faible quantité des données existantes, nous avons évalué la qualité de vie 
liée à la santé (QVLS) des Philippins suivant un traitement antituberculeux ; et si ce dernier était 
négativement affecté par des comorbidités telles que la malnutrition, le diabète et l’anémie.  
Méthodes: Les participants adultes ont été recrutés dans des établissements publics du Grand 
Manille (3 sites) et de Negros occidental (2 sites). 
Nous avons utilisé une régression linéaire multivariée pour modeler les quatre scores de domaine 
corrélés du questionnaire WHOQHOL-BREF (physique, psychologique, social, environnemental). La 
méthode ascendante pas à pas a été utilisée pour choisir un modèle multivarié final avec inclusion 
basée sur des tests de signification dont p<0.1.  
Résultats: Chez 446 personnes sous traitement contre la tuberculose pharmacosensible, le diabète 
et l’anémie modérée ou sévère n’ont pas été associés avec la QVLS. Après pondération de l’âge, du 
sexe, du niveau d’éducation atteint, de l’insécurité alimentaire, de l’adhésion au traitement, de 
l’inflammation, de la catégorie de traitement antituberculeux (I ou II), de la phase de traitement, des 
effets secondaires contemporains au traitement et réduction de la capacité à travailler, la sous-
nutrition modérée ou sévère (IMC <17 kg/m2) a été associée à une QVLS plus faible (p=0.003) avec 
une réduction des scores pour les domaines psychologiques (coefficient: -1.02; intervalle de 
confiance à 95%: -1.54-0.51), physiques (-0.62; -1,14-0.09) et environnementaux (-0,45; -0.88-0.01). 
Chez 225 patients du Grand Manille dont le statut VIH était connu, la séropositivité a été associé 
avec une QVLS modérément réduite (p=0.014). 
Conclusions : Le statut nutritionnel et l’insécurité alimentaire représentent des facteurs de risques 
évitables vis-à-vis de la QVLS qui peuvent atténués au travers d’interventions. 
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INTRODUCTION 1 
Tuberculosis (TB) is a leading cause of morbidity in many high burden countries1  and although 2 
increasing attention is being paid to the impact of TB beyond physical health, including psychosocial 3 
and financial impacts, the effects of common co-morbid conditions such as HIV, diabetes, acute 4 
malnutrition and anaemia on patient’s overall well-being is not known. 5 
Understanding how TB impacts the quality of life as perceived by individuals, is important for 6 
understanding how to improve patient-centred care (a component of pillar 1 in the End TB strategy 7 
20352  and also in the evaluation of interventions and for health policy, since data on health-related 8 
quality of life (HrQoL) are used in health economic evaluations.  HrQoL encompasses the physical, 9 
mental and social well-being of individuals. How these are perceived is dependent on the society and 10 
environment of individuals. Studies in a range of settings have reported negative impacts of TB 11 
disease on individual’s HrQoL, using an assortment of mostly generic tools applicable to different 12 
health conditions. Some of these studies included an appropriate comparison population groups of 13 
individuals without TB disease or with latent TB infection or reference population norms3, 4. Very few 14 
studies in persons with active TB disease have included assessment of the impact of co-morbidities 15 
on HrQoL, although a recent  prospective cohort study in India reported a negative effect of diabetes 16 
using the TB-specific Dhingra and Rajpal (DR-12) scale55.  17 
Although the Philippines has a high TB burden, there are currently very limited HrQoL data from the 18 
Philippines or on co-morbidities in TB. Within a cross-sectional study of Filipino persons with active 19 
TB disease, we investigated, as a primary objective, the prevalence of diabetes and moderate/severe 20 
acute undernutrition and factors associated with these co-morbidities, reported elsewhere (White et 21 
al. under review). Here, we report investigations of whether co-morbidities of undernutrition, 22 
diabetes and moderate or severe anaemia and HIV infection are associated with reduced HrQoL in 23 
this population.   24 
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METHODS 25 
Study Design 26 
Here we present previously unreported data as a secondary objective of a cross-sectional survey of 27 
persons enrolled in TB-DOTS clinics (ISRCTN12506117) described in detail elsewhere (White et al. 28 
under review). 29 
Study Setting 30 
The Philippines is a middle-income country, currently estimated to have the third highest TB 31 
incidence of 554/100,000 population occurring in the context of a low HIV prevalence, estimated at 32 
2% of incident TB cases, although HIV testing is low in many areas. The prevalence of undernutrition 33 
(BMI<18.5kg/m2) in Filipino adults was 10% in the 2014 National Nutrition Survey. Three public TB-34 
DOTS clinics in Metro Manila provided data from an urban setting, including the TB-DOTS at San 35 
Lazaro Hospital, an infectious disease referral hospital, serving a predominantly poor population.  36 
Metro Manila is identified as a category “A” area with a high burden for HIV compared to other 37 
areas of the country. Two public TB-DOTS clinics in Negros Occidental provided data from a rural 38 
setting.  39 
Participants 40 
All adults (³18 years), but excluding pregnant women, whose TB-DOTS registration date at 41 
participating TBDOTS clinics indicated that TB treatment should be ongoing were eligible to 42 
participate. Recruitment involved research nurses travelling out into the barangays (villages) to 43 
attempt to locate all those whose treatment was supposed to be ongoing.  44 
Outcome 45 
The primary outcome of interest was health-related quality of life (HrQoL) assessed using the World 46 
Health Organisation Quality of Life-BREF (WHOQOL-BREF) assessment6  translated into local 47 
languages (Filipino and Hilagaynon) and administered by trained research nurses. Responses to 24 of 48 
the 26 items in WHO HrQoL-BREF are used to score four domains: (i) physical; (ii) psychological; (iii) 49 
social relationships; and, (iv) environment. Domain scores were calculated according to the standard 50 
algorithm (with a possible range of 4-20) 7. Higher domain scores reflect better HrQoL.  51 
Data collection and definitions of comorbidity exposures and other covariates 52 
Trained multilingual research nurses completed all study assessments using questionnaires and tools 53 
translated into local languages and extracted information recorded on individuals’ National TB 54 
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Program treatment cards in the language of the participants choice (Filipino, Hilagaynon or English). 55 
Household food security was assessed using the Adapted U.S. Household Food Security Survey 56 
Module (US HFSSM), previously validated for use in the Philippines and used the standard tool-57 
specific cut-offs to generate the categories of household food secure, moderate insecurity and severe 58 
insecurity8. Data were entered directly into Open Data Kit software and uploaded to a secure server 59 
daily. Research nurses conducted anthropometry, as previously reported (White et al, under review) 60 
but in brief, included weight to the nearest 0.1kg; height, mid-upper arm circumference (MUAC) and 61 
waist and hip circumferences to the nearest 0.5 cm; and grip strength to the nearest kg, (Jamar 62 
Hydraulic Hand Dynamometer Lafayette Instruments, USA) recorded as the highest value obtained 63 
from 3 measurements of the dominant hand. Fingerprick blood samples were used to obtain 64 
haemoglobin (HemoCue 301, Ängelholm, Sweden), glycosylated haemoglobin (HbA1C) and C-65 
reactive protein (CRP) (Alere Afinion AS100 Analyzer) and conduct HIV screening (Standard 66 
Diagnostics Bioline HIV-1/2 Ag/Ab Combo Rapid Test kits) for those with unknown status and who 67 
provided additional consent.   68 
Comorbid conditions considered in this analysis included undernutrition assessed using body mass 69 
index (BMI) defined as moderate/severe undernutrition (BMI <17.0 kg/m2). Diabetes was defined as 70 
HBA1c >=6.5% or receiving treatment for diabetes at the time of enrolment. Moderate or severe 71 
anaemia was defined as haemoglobin <11g/dL. HIV co-infection was defined as a positive screening 72 
test result or a previous diagnosis. Potential confounders and other independent risk factors 73 
measured in the study included: i) socio-demographic characteristics: age, sex, urban/rural area 74 
study area, marital status, level of education, distance/time to TBDOTS centre, health insurance, 75 
level of household food security, smoking and alcohol consumption and factors relating to impact of 76 
TB on ability to work and cover expenses; ii) health and TB related factors: TB category (new vs. 77 
relapse etc) phase of TB treatment (intensive vs. continuation),  current side effects of TB treatment, 78 
adherence to TB treatment in the previous week, category of medication (Category I or II) presence 79 
of inflammation (CRP>5g/L) and hand grip strength as a measure of functional nutritional status. 80 
Sample Size 81 
Sample size for this study was determined by the number of participants required for the main study 82 
of undernutrition and diabetes co-morbidity in persons with TB attending TBDOTS clinics in Metro 83 
Manila and Negros Occidental. There were 614 participants with drug sensitive TB in the TB 84 
comorbidity study, of whom 446 were interviewed using the QoL questionnaire. Sample size 85 
calculations for the secondary outcome of HrQoL were not included in the protocol. 86 
Statistical methods 87 
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Data were analyzed using Stata, version 15.1 (College Station TX: StataCorp LP) and R9. 88 
Characteristics of all enrolled participants and for those with complete HrQoL data were 89 
summarised.   90 
Physical, psychological, social and environmental domain scores were summarised as mean 91 
(standard deviation, SD) overall and within categories of categorical independent variables, after 92 
observing data to be approximately normally distributed.  93 
Due to correlation between QoL domain scores within individuals, multivariate linear regression was 94 
used to allow for simultaneous modelling of the four QoL outcomes in the same regression model. 95 
For each independent variable, regardless of the number of variable categories, global tests of 96 
association were conducted for association with the four domains to reduce multiple testing10. 97 
Multivariable multivariate linear regression model building was carried out using a forward stepwise 98 
approach, in blocks of related exposures, where blocks comprised i) comorbidities; ii) demographic 99 
and socio-economic indicators; and, iii) TB related factors. Independent variables were retained if 100 
the global test of association p-value, after adjustment for other variables was <0.1. Sex was 101 
included in the multivariable model a priori. In the final adjusted model, the strength of association 102 
between independent variables and QoL domain scores was interpreted with and without 103 
Bonferroni adjustment for the number of tests of association in the final model (alpha=0.05/number 104 
of tests of association (covariates) in the final model). 105 
Ethics 106 
Ethical approval was obtained from Institutional Ethics Review Boards at Nagasaki University (School 107 
of Tropical Medicine and Global Health), London School of Hygiene and Tropical Medicine, 108 
Philippines National Ethics Committee, and San Lazaro Hospital in Manila. Written consent was 109 
obtained from all participants prior to study enrolment and additional written consent was obtained 110 
for HIV screening following Department of Health procedures.  111 
 112 
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RESULTS 113 
Of 614 participants on non-drug resistant TB-regimens enrolled between 08 May and 18 September 114 
2017, 446 were interviewed for HrQoL between 19 May and 18 September 2017. The 446 115 
participant sub-set included in this analysis (hereafter referred to as the study population) were 116 
similar to the total study population, except that a greater proportion of those with HrQoL were 117 
enrolled in urban Metro Manila compared to rural Negros Occidental (Table 1). Males comprised 118 
70% of the study population and participant mean age was 44.8 years (SD 16.7). Participants were 119 
significantly older in Negros Occidental compared to Metro Manila (50.5 vs. 41.1 years; p<0.001), 120 
with no difference in age by sex (p=0.280). The proportion of participants with previously treated TB 121 
(i.e. programmatically defined as relapse, treatment after failure, previous treatment outcome 122 
unknown or treatment after loss to follow-up) was 30.3% (134/443). There was no evidence that the 123 
proportion of previously treated cases differed by urban/rural area or by sex but did increase with 124 
age, from 17.4% of the 18-40 years age group, 40% of the 41-65 years age group to 45.6% of the >65 125 
years age group (p<0.001). This is relevant, because in this setting, previously treated cases were 126 
treated with Category II TB treatment including daily injectable streptomycin during the intensive 127 
phase of treatment.  128 
The prevalence of diabetes in the study population was 8.3% (37/446) with just over half (19/37) 129 
newly captured by the study protocol (HbA1C≥6.5%). The prevalence of moderate and severe 130 
undernutrition (BMI<17 kg/m2) was 19.8% (88/445), moderate/severe anaemia 131 
(haemoglobin<11g/dL) was 15.8% (70/443) and self-reported hypertension was 9.0% (40/446).  HIV 132 
status was unknown for the majority of participants in Negros Occidental, due to screening refusal. 133 
In Metro Manila, HIV status was known for 88% (238/270) of participants, in whom 28.6% were 134 
infected. All but 4/68 had been previously diagnosed and the majority (54/64) were on anti-135 
retroviral therapy.  Most of these participants (63/68) were enrolled at San Lazaro Hospital, an HIV 136 
referral centre, accounting for the high proportion of HIV co-morbidity in our urban study 137 
population.  138 
There were no missing data for any of the individual items on the WHOQOL-BREF. Domain scores 139 
were approximately normally distributed with a range of scores, although the psychological domain 140 
showed a grouping of middles scores and also outliers (Figure 1). Internal consistency across domain 141 
components was good for the physical, psychological and environmental domains (Cronbach’s alpha 142 
coefficient >0.7) but poor for the social relationships’ domain (Cronbach’s alpha coefficient =0.46).  143 
For the single (national item) of overall rating of quality of life, 22.0% (98/446) rated their quality of 144 
life as poor or very poor, and 35.9% (160/446) as good or very good. This compared to 37.9% 145 
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(169/446) who reported being dissatisfied or very dissatisfied with their health and 26.5% (118/446) 146 
who were satisfied or very satisfied.  147 
Mean domain scores are shown in Tables 2, 3 and 4. In univariable, multivariate analysis there was 148 
no evidence of an association between diabetes, anaemia or reported hypertension with HrQoL 149 
domain scores (Table 2). However, moderate/severe undernutrition (BMI<17 kg/m2) was 150 
significantly associated (global test of association p<0.001) with reduced scores for the physical and 151 
psychological domains. Similarly, grip strength as a measure of functional nutritional status was 152 
positively associated with higher domain scores (p<0.001, Table 2), whilst moderate and severe 153 
levels of household food insecurity were associated with reduced scores (p<0.001, Table 3). For 154 
those with known HIV status in Metro Manila, HIV infection was associated with HrQoL domain 155 
scores (p<0.001, Table 2), with evidence of increased scores for the physical and environmental 156 
domains.  We also assessed associations with indicators of the possible impact of TB on ability to 157 
work, and consequences for household finances, which both showed evidence of negatively 158 
affecting HrQoL scores (p<0.001, Table 3). Finally, TB specific factors were assessed; all of which, 159 
apart from the basis of diagnosis (bacteriological vs clinical) were significantly associated (Table 4).  160 
Effects for factors retained in the final model are shown in Table 5. The association between HrQoL 161 
and undernutrition remained after adjustment for other exposures with the greatest reduction in 162 
the psychological domain. Moderate or severe food insecurity showed a dose response effect of 163 
decreased scores for all domains (Figure 2A). When considering a Bonferroni adjustment to account 164 
for 12 global tests (alpha of 0.05/12 = 0.004) undernutrition and household food security remained 165 
strongly associated with HrQoL.  166 
When adjusting for area (urban/rural) in the final model, area was strongly associated with QoL 167 
scores (p<0.001) and effects of adherence and undernutrition were reduced (global test p=0.078 and 168 
p=0.058), as these differed by area (93% in Negros Occidental adhered fully in the last 7 days 169 
compared to 62% in Manila, chi-squared p<0.001; and 30% vs 15% severe/moderate undernutrition 170 
in Negros Occidental and Manila, p=0.002). Household food security was not associated with 171 
undernutrition overall or by area, but did differ by area (approximately two-thirds moderate/severe 172 
food insecurity in Negros compared to one-third in Manila, p<0.001). Undernutrition and recent 173 
adherence were retained in the model over area as more specifically measured covariates of 174 
interest. 175 
The final model was fitted to participants from Metro Manilla with known HIV status and non-176 
missing values for factors in the final model (225/255) (Table S1). After adjustment, HIV was 177 
associated with QoL overall (p=0.014, Fig 2B) with the largest observed negative point estimates for 178 
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the psychological domain (coefficient: -0.49; -1.25 to 0.26), then environmental score (coefficient: -179 
0.12; -0.91 to 0.67). In this model, the effects of undernutrition and adherence were no longer 180 
present but food insecurity remained a strong risk factor for reduced QoL (p<0.001). In this sub-181 
group, HIV was strongly associated with increased level of education (p<0.001) which likely 182 
represents a proxy for socio-economic status (60% of those with tertiary education had HIV) and sex 183 
(40% of male participants versus 3% of women had HIV, p<0.001 and the previously observed effect 184 
of sex on QoL was not seen in this sub-group).185 
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DISCUSSION 186 
We focussed on the effect of diabetes and undernutrition on Hr-QoL as these are common co-morbid 187 
conditions.  The prevalence of undernutrition is much higher than in the general adult population (10% BMI 188 
<18.5)11, whilst the national prevalence of diabetes is estimated at 5.8%12. Furthermore, the diagnosis and 189 
management of diabetes and undernutrition are recommended as part of integrated patient centred care, 190 
but current implementation is limited2, 13.  191 
In this population, we demonstrated that undernutrition was independently associated with lower 192 
perceived quality of life in the physical, psychological and environmental domains. No effects were 193 
observed for diabetes or anaemia. Furthermore, we explored if effects of diabetes may be limited to those 194 
with existing diagnoses or those with uncontrolled (HbA1c>=8%) compared to controlled diabetes, but saw 195 
no evidence of associations, although low numbers of observations will have limited the probability of 196 
detecting all but large effects. In addition to undernutrition, household food insecurity was associated in a 197 
dose-response manner with reduced scores across all four domains. In a previous cross-sectional study of 198 
Hr-QoL using the Short Form-8 (a shorter version of the Short Form-36) in 520 Filipino TB patients enrolled 199 
in TBDOTS in Metro Manila, the mental component summary score, but not the physical component 200 
summary score was independently associated with increasing BMI14.  Although the use of financial or in-201 
kind support for travel or food as incentives or enablers for persons undergoing TB treatment are widely 202 
advocated to increase treatment uptake and completion and as means of poverty alleviation15, no such 203 
programmes were available at the time of our study for patients enrolled in non-MDR TB treatment 204 
regimens.  Therefore, we could not investigate if such provisions might impact quality of life, and if 205 
mediated through effects on nutritional status or household food security.  We are not aware of any 206 
studies that have assessed this.  In India, large increases in WHOQOL-BREF domain scores were observed 207 
between start of TB treatment and end of intensive phase and end of treatment16. The mean scores at end 208 
of treatment were the most comparable to those we observed (scores transformed onto the 0-100 scale of 209 
66 (environment domain) to 80 (physical domain)), equivalent to approximately 14.5 and 16.5 on the 4-20 210 
scale we report). Over the course of treatment, the largest improvement in QoL was observed for the 211 
physical domain (nearly doubled), but comorbidities were not assessed16. In another more recent study in 212 
India, using the TB-specific Dhingra & Rajpal DR-12 scale the authors reported decreased scores in the 213 
socio-psychological and exercise adaptation domains in persons with diabetes, but limited to those aged 214 
over 50 years; whilst uncontrolled compared to controlled diabetes was associated with lower symptom 215 
score and total scores – but only at the end of TB treatment5.  Although there was a high prevalence of 216 
severe undernutrition in this population (23% had body mass index [BMI] <15 kg/m2) a possible effect of 217 
this important co-morbidity was not reported5.  Within the sub-set of participants with known HIV status, 218 
living with HIV infection appeared to be associated with increased QoL domain scores. However, after 219 
adjustment in the multivariable model, which included age and education which were higher in those with 220 
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HIV and also positively associated with QoL domain scores, this association trended towards decreased 221 
scores. Thus, compared to other studies in Ethiopia the impact of co-morbid HIV appeared to be limited17, 222 
18. As the majority of those living with HIV were already in care at the same site as their TB treatment and 223 
receiving anti-retroviral therapy, this suggests that in the context of adequate care, the additional impact of 224 
comorbid-HIV in tuberculosis is not necessarily great. The level of impact may vary depending on the extent 225 
of integrated management of the two conditions and availability of coping/support mechanisms in HIV 226 
care.  227 
Although there is evidence that QoL scores increase with duration of treatment, they may not resolve to 228 
pre-disease levels due to the increasingly recognised long-term effects of TB disease, including chronic lung 229 
disorders, requiring long-term further management19. Simple physical therapy rehabilitation interventions 230 
may be beneficial in improving lung-function and also quality of life, especially in the physical domain20.  231 
The potential limitations of this study include the lack of normative data in representative Filipino adults to 232 
compare our observations with, together with the low internal consistency across the items in the social 233 
relationships’ domain, which may indicate that more adaptation is needed of this tool to the Filipino or TB 234 
setting.  Further limitations include those inherent in cross-sectional studies. However, selection bias was 235 
minimised by the inclusion of participants across the range of treatment duration and of persons who were 236 
attending the TB-DOTS clinics less frequently through tracing at home visits. Meanwhile, measurement bias 237 
of the exposures was minimised by the use of trained study nurses to assess nutritional status and 238 
screening of diabetes in all participants, rather than relying on routinely collected data. On the other hand, 239 
the use of a single measurement of HbA1c >=6.5% may have resulted in wrongly classifying some persons 240 
as having diabetes, due to mild increases in HbA1c from temporary glucose dysregulation induced by TB.  241 
Conclusions 242 
Evidence of the psychosocial effects of undernutrition, additional to direct biomedical effects on TB 243 
treatment outcomes provides further evidence to: (1) support the need for nutrition interventions; (2) 244 
include additional outcomes such as Hr-QoL and mental health related measures to determine impacts of 245 
nutrition interventions; and, (3) identify individuals who might benefit from additional psychosocial 246 
support. The measurement of household food insecurity within TB programmes may be a sensitive 247 
indicator of household poverty and stress, which may be alleviated through social protection mechanisms 248 
aimed at the whole household and directly or indirectly improving household food security and potentially 249 
Hr-QoL.  250 
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Tables & Figures  
Table 1. Characteristics of persons on drug-sensitive TB treatment regimens in all enrolled participants 
and in those in whom quality of life was assessed.   
  Enrolled N=604 QoL data N=446 
Area Metro Manila 305 (50.5) 270 (60.5) 
Negros Occidental 299 (49.5) 176 (39.5) 
Urban sites (Metro 
Manila) 
San Nicholas 107 (17.7) 87 (19.5) 
Pedro Gil 102 (16.9) 87 (19.5) 
San Lazaro Hospital 96 (15.9) 96 (21.5) 
Rural sites (Negros 
Occidental) 
Valladolid 77 (12.7) 22 (4.9) 
Bago City 222 (36.8) 154 (34.5) 
Sex Female 178 (29.5) 129 (28.9) 
Male 426 (70.5) 317 (71.1) 
Age category (years) 18-40 252 (41.7) 197 (44.2) 
41-65 270 (44.7) 192 (43.0) 
>65 82 (13.6) 57 (12.8) 
Marital status Single 239 (39.6) 188 (42.2) 
Married 284 (47.0) 203 (45.5) 
Divorced/separated 14 (2.3) 10 (2.2) 
Widowed 67 (11.1) 45 (10.1) 
Maximum education 
obtained 
Primary 215 (35.6) 145 (32.5) 
Secondary 227 (37.6) 168 (37.7) 
Tertiary 142 (23.5) 121 (27.1) 
Vocational 20 (3.3) 12 (2.7) 
Household Food 
insecurity 
Food Secure 307 (50.8) 234 (52.5) 
Moderate insecurity 157 (26.0) 105 (23.5) 
Severe insecurity 140 (23.2) 107 (24.0) 
Smoking status No or Ex-Smoker 480 (79.5) 369 (82.7) 
Yes 124 (20.5) 77 (17.3) 
Alcohol consumption 
pre-TB 
Daily 111 (18.4) 77 (17.3) 
Weekly or Monthly 132 (21.9) 99 (22.2) 
Rarely/Never 361 (59.8) 270 (60.5) 
Phase of treatment Intensive 309 (51.2) 240 (53.8) 
Continuation 295 (48.8) 206 (46.2) 
Undernutrition1 Normal/Mild 480 (79.5) 357 (80.0) 
Moderate/Severe 121 (20.0) 88 (19.7) 
Anaemia2 None/mild 514 (85.1) 373 (83.6) 
Moderate/Severe 85 (14.1) 70 (15.7) 
Diabetes3 Not diabetic 507 (83.9) 409 (91.7) 
New diagnosis 27 (4.5) 19 (4.3) 
Existing diagnosis 22 (3.6) 18 (4.0) 
Data are n (%)  
Missing data: anaemia (3), undernutrition (1) 
1 Moderate/severe: BMI≥17kg/m2, Mild/normal: BMI<17kg/m2. 
2 Moderate/severe: Haemoglobin<11g/dL, Mild/normal: Haemoglobin ≥11g/dL 
3 New diagnosis: previously undiagnosed with HbA1c >=6.5%; existing: previously diagnosed with diabetes 
 
 16 
Table 2: Summary of health-related quality of life domain scores in persons on drug-sensitive TB treatment regimens by clinical comorbid characteristics  
   Hr-QoL domain, mean (SD)  
  N Physical Psychological Social Environmental p-value1 
Overall 446 13.4 (2.4) 13.7 (2.2) 14.6 (2.0) 13.3 (2.0)  
Undernutrition2 None/mild 357 13.7 (2.3) 13.8 (2.1) 14.7 (1.9) 13.4 (2.0) <0.001 
Moderate/Severe 88 12.6 (2.5) 12.9 (2.2) 14.5 (2.3) 13.0 (1.9)  
Anaemia3 None/mild 373 13.5 (2.4) 13.8 (2.2) 14.7 (2.0) 13.4 (1.9) 0.182 
Moderate/Severe 70 13.0 (2.4) 13.1 (2.2) 14.3 (2.0) 12.9 (2.0)  
Diabetes4 No 409 13.5 (2.4) 13.7 (2.2) 14.6 (2.0) 13.3 (2.0) 0.590 
Yes 37 13.2 (2.3) 13.6 (2.2) 14.9 (1.8) 13.6 (1.5)  
Diabetes diagnosis5 Not diabetic 409 13.5 (2.4) 13.7 (2.2) 14.6 (2.0) 13.3 (2.0) 0.773 
New diagnosis 19 13.1 (2.2) 13.8 (1.7) 15.2 (1.4) 13.5 (1.6)  
Existing diagnosis 18 13.4 (2.5) 13.4 (2.6) 14.6 (2.1) 13.6 (1.5)  
Diabetes control6 Not diabetic 409 13.5 (2.4) 13.7 (2.2) 14.6 (2.0) 13.3 (2.0) 0.570 
Controlled 14 13.9 (2.6) 14.0 (2.4) 14.7 (2.0) 13.6 (1.6)  
Uncontrolled 23 12.8 (2.0) 13.4 (2.0) 15.1 (1.7) 13.5 (1.5)  
Self-reported Hypertension No 406 13.5 (2.4) 13.7 (2.2) 14.7 (2.0) 13.4 (2.0) 0.072 
Yes 40 12.4 (2.1) 13.2 (2.0) 14.3 (1.9) 12.7 (1.9)  
Number of comorbidities 
(undernutrition, anaemia, 
diabetes, hypertension) 
0 262 13.8 (2.4) 14.0 (2.1) 14.8 (1.9) 13.5 (2.0) 0.004 
1 137 13.3 (2.4) 13.3 (2.3) 14.5 (2.2) 13.3 (1.9)  
2 43 12.1 (1.9) 12.9 (1.9) 14.4 (1.9) 12.6 (1.8)  
3 4 12.1 (3.8) 12.3 (2.5) 14.7 (1.9) 12.5 (2.0)  
Inflammation No: CRP7 <5 g/L 369 13.7 (2.4) 13.8 (2.2) 14.7 (2.1) 13.4 (2.0) 0.010 
Yes: CRP >=5 g/L 34 12.3 (2.6) 12.6 (1.9) 13.7 (1.8) 12.6 (1.8)  
Hand grip strength (kg) 445 - - - - <0.001 
        
HIV infection (Manila only) No 170 13.5 (2.5) 14.2 (2.1) 14.8 (2.1) 13.1 (2.0) <0.001 
Yes 68 14.5 (1.7) 14.2 (1.9) 14.8 (1.8) 14.7 (1.5)  
1 global p-value from univariable multivariate linear regression 
2 Moderate/severe: BMI≥17kg/m2, Mild/normal: BMI<17kg/m2  
3 Moderate/severe: Haemoglobin<11g/dL, Mild/normal: Haemoglobin ≥11g/dL 
4 Diabetes: HbA1c >=6.5% or on diabetes drug treatment 
5 New diagnosis: previously undiagnosed with HbA1c >=6.5%; existing: previously diagnosed with diabetes 
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6 Controlled diabetes: on diabetes drug treatment and HbA1c<8.0%; uncontrolled diabetes: HbA1c>=8% 
7 CRP: C-reactive protein 
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Table 3. Summary of health-related quality of life domain scores in persons on drug-sensitive TB treatment regimens by demographic and socio-economic 
patient characteristics 
   Hr-QoL domain, mean (SD) 
  N Physical Psychological Social  Environmental p-value1 
Area Metro Manila 270 13.9 (2.4) 14.3 (2.0) 14.8 (2.0) 13.6 (2.0) <0.001 
Negros Occidental 176 12.7 (2.3) 12.7 (2.1) 14.4 (2.0) 12.9 (1.9)  
Sex Female 129 13.6 (2.2) 14.0 (2.2) 14.9 (2.1) 13.4 (1.9) 0.221 
Male 317 13.4 (2.5) 13.5 (2.2) 14.5 (2.0) 13.3 (2.0)  
Age category (years) 18-40 197 14.2 (2.3) 14.2 (2.1) 14.9 (1.9) 14.0 (1.9) <0.001 
41-65 192 13.0 (2.3) 13.4 (2.0) 14.6 (2.0) 12.8 (1.8)  
>65 57 12.3 (2.5) 12.7 (2.7) 13.9 (2.3) 12.8 (1.9)  
Marital status Single 188 13.9 (2.5) 14.0 (2.2) 14.8 (2.0) 13.9 (2.0) <0.001 
Married 203 13.2 (2.3) 13.6 (2.0) 14.7 (1.9) 13.0 (1.8)  
Divorced/separated 10 12.9 (1.8) 12.7 (2.3) 13.2 (2.4) 12.6 (1.6)  
Widowed 45 12.5 (2.3) 12.9 (2.5) 14.1 (2.1) 12.7 (1.9)  
Maximum education 
obtained 
Primary 145 12.5 (2.2) 13.1 (2.1) 14.3 (2.1) 12.6 (1.8) <0.001 
Secondary 168 13.4 (2.4) 13.8 (2.1) 14.8 (2.0) 13.2 (1.8)  
Tertiary 121 14.6 (2.3) 14.3 (2.2) 14.8 (1.9) 14.5 (1.8)  
Vocational 12 13.3 (2.0) 12.7 (2.2) 14.6 (1.3) 13.2 (2.0)  
Smoking status No or Ex 369 13.6 (2.3) 13.8 (2.0) 14.7 (1.9) 13.4 (1.9) 0.047 
Yes 77 12.8 (2.8) 13.1 (2.7) 14.1 (2.5) 12.8 (2.2)  
Alcohol consumption 
pre-TB 
Daily 77 12.5 (2.5) 12.9 (1.9) 14.3 (2.0) 12.8 (1.8) 0.013 
Weekly or Monthly 99 13.6 (2.3) 13.5 (2.1) 14.5 (2.0) 13.3 (1.9)  
Rarely/Never 270 13.7 (2.4) 13.9 (2.2) 14.8 (2.0) 13.5 (2.0)  
Household food security Secure 234 14.1 (2.2) 14.1 (2.1) 15.0 (2.0) 14.1 (1.8) <0.001 
Moderate insecurity 105 12.8 (2.4) 13.2 (2.3) 14.4 (2.2) 12.7 (2.0)  
Severe insecurity 107 12.6 (2.4) 13.1 (2.0) 14.2 (1.9) 12.4 (1.7)  
Ability to work affected No 236 13.6 (2.4) 14.0 (2.2) 14.9 (2.0) 13.3 (2.0) <0.001 
Yes 208 13.3 (2.5) 13.3 (2.1) 14.3 (2.0) 13.3 (1.9)  
Money shortages to 
cover TB expenses 
No 192 14.2 (2.1) 14.2 (2.1) 15.0 (1.9) 14.1 (2.0) <0.001 
Yes 254 12.9 (2.5) 13.3 (2.2) 14.4 (2.1) 12.8 (1.7)  
1 global p-value from univariable multivariate linear regression  
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Table 4. Summary of health-related quality of life domain scores in persons on drug-sensitive TB treatment regimens by TB related factors 
   Hr-QoL domain, mean (SD) 
  N Physical Psychological Social  Environmental p-value1 
TB treatment phase Intensive 240 13.0 (2.5) 13.4 (2.3) 14.6 (2.1) 13.2 (1.9) 0.001 
Continuation 206 14.0 (2.2) 13.9 (2.0) 14.7 (1.9) 13.5 (2.0)  
Current treatment 
side effects 
Yes 134 12.6 (2.6) 13.1 (2.6) 14.4 (2.2) 12.9 (2.0) <0.001 
No 312 13.8 (2.3) 13.9 (1.9) 14.8 (1.9) 13.5 (1.9)  
TB treatment 
category 
Category I 307 13.8 (2.2) 14.0 (2.1) 14.9 (1.9) 13.5 (1.9) <0.001 
Category II 139 12.5 (2.7) 13.0 (2.3) 14.0 (2.2) 12.9 (2.0)  
TB bacteriologically 
confirmed 
No 299 13.5 (2.5) 13.7 (2.2) 14.7 (1.9) 13.2 (1.9) 0.581 
Yes 139 13.3 (2.3) 13.6 (2.2) 14.5 (2.2) 13.4 (2.0)  
TB category New case 309 13.8 (2.2) 13.9 (2.0) 14.9 (1.9) 13.5 (1.9) <0.001 
Relapse/Treatment failure/TALF/PTOU2 134 12.5 (2.7) 13.0 (2.4) 14.0 (2.1) 12.8 (2.0)  
Number of days adherent in last 7 days 442     0.001 
1 global p-value from univariable multivariate linear regression 
2 Programmatic TB categories TALF: treatment after loss to follow-up; PTOU: previous treatment outcome unknown  
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Table 5. Multivariable multivariate regression of health-related quality of life analysis in persons on drug-sensitive TB treatment regimens 
   Hr-QoL domain, linear regression coefficient (95% CI) 
  Physical Psychological Social Environmental p-value1 
Sex Female      
Male -0.88 (-1.44 to -0.32) -0.42 (-0.97 to 0.13) -0.14 (-0.68 to 0.39) -0.21 (-0.68 to 0.25) 0.039 
Age (years) 18-40      
41-65 -0.18 (-0.70 to 0.33) -0.50 (-1.00 to 0.01) -0.19 (-0.68 to 0.30) -0.48 (-0.90 to -0.05) 0.073 
>65 -0.75 (-1.54 to 0.04) -0.96 (-1.74 to -0.18) -0.82 (-1.57 to -0.06) -0.48 (-1.14 to 0.18)  
Maximum education 
obtained 
Primary      
Secondary 0.42 (-0.11 to 0.95) 0.42 (-0.10 to 0.94) 0.24 (-0.26 to 0.75) 0.39 (-0.05 to 0.83) <0.001 
Tertiary 1.01 (0.35 to 1.66) 0.40 (-0.24 to 1.04) -0.10 (-0.72 to 0.52) 1.20 (0.66 to 1.74)  
Vocational 0.13 (-1.24 to 1.49) -0.62 (-1.96 to 0.72) 0.07 (-1.23 to 1.37) 0.49 (-0.64 to 1.62)  
Household food 
security 
Secure      
Moderate insecurity -0.66 (-1.20 to -0.12) -0.57 (-1.10 to -0.03) -0.64 (-1.16 to -0.12) -0.93 (-1.38 to -0.48) <0.001 
Severe insecurity -0.78 (-1.35 to -0.22) -0.82 (-1.38 to -0.27) -1.00 (-1.53 to -0.46) -1.25 (-1.71 to -0.78)  
Undernutrition2 No      
Yes -0.62 (-1.14 to -0.09) -1.02 (-1.54 to -0.51) -0.20 (-0.70 to 0.30) -0.45 (-0.88 to -0.01) 0.003 
Inflammation No: CRP <5 g/l      
 Yes: CRP 5+ g/l -0.96 (-1.73 to -0.19) -1.14 (-1.90 to -0.39) -0.97 (-1.71 to -0.24) -0.90 (-1.54 to -0.27) 0.017 
Hand grip strength 0.05 (0.02 to 0.08) 0.00 (-0.03 to 0.03) -0.00 (-0.03 to 0.03) -0.01 (-0.03 to 0.01) <0.001 
Phase of treatment Intensive      
Continuation 0.51 (0.06 to 0.97) 0.28 (-0.16 to 0.73) -0.09 (-0.52 to 0.34) -0.14 (-0.51 to 0.24) 0.025 
TB treatment 
category 
Category 1      
Category 2 -0.65 (-1.11 to -0.19) -0.46 (-0.92 to -0.01) -0.75 (-1.19 to -0.31) -0.22 (-0.60 to 0.17) 0.002 
Current treatment 
side effects 
No      
Yes 0.76 (0.30 to 1.22) 0.41 (-0.04 to 0.86) 0.16 (-0.27 to 0.60) 0.41 (0.03 to 0.79) 0.026 
Ability to work 
affected 
No      
Yes -0.48 (-0.91 to -0.05) -0.72 (-1.15 to -0.30) -0.74 (-1.15 to -0.33) -0.20 (-0.56 to 0.16) <0.001 
Number of days adherent in last 7 days 0.03 (-0.05 to 0.11) -0.06 (-0.14 to 0.02) 0.01 (-0.07 to 0.09) 0.10 (0.03 to 0.17) <0.001 
Based on N=392 after exclusion of missing values (total m=54: BMI m=1, grip strength m=1, work ability m=2, adherence m=4, CRP m=43).  
Bold type indicates 95% CIs excluding the null effect. 
1 global p-value from multivariable multivariate linear regression 
2 Moderate/severe: BMI≥17kg/m2, Mild/normal: BMI<17kg/m2  
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Table S1. Multivariable multivariate regression analysis of health-related quality of life in persons on drug-sensitive TB treatment regimens in Manilla with HIV 
status/test result available 
  Hr-QoL domain, linear regression coefficient (95% CI) 
  Physical Psychological Social Environmental p-value1 
Sex Female      
Male -0.87 (-1.63 to -0.10) -0.88 (-1.59 to -0.17) -0.72 (-1.47 to 0.03) -0.64 (-1.27 to 0.00) 0.106 
Age (years) 18-40      
41-65 -0.53 (-1.20 to 0.14) -0.68 (-1.30 to -0.05) -0.30 (-0.96 to 0.35) -0.64 (-1.19 to -0.08) 0.012 
>65 -1.47 (-2.62 to -0.33) -0.93 (-1.99 to 0.13) -0.33 (-1.45 to 0.79) 0.05 (-0.90 to 1.01)  
Maximum education 
obtained 
Primary      
Secondary 0.79 (0.03 to 1.54) 0.57 (-0.13 to 1.28) 0.41 (-0.33 to 1.16) 1.03 (0.40 to 1.66) <0.001 
Tertiary 0.90 (0.03 to 1.77) 0.19 (-0.61 to 1.00) -0.41 (-1.26 to 0.44) 1.40 (0.68 to 2.13)  
Vocational 1.32 (-1.06 to 3.70) 0.40 (-1.81 to 2.60) 0.54 (-1.79 to 2.87) 1.23 (-0.75 to 3.21)  
Household food 
security 
Secure      
Moderate insecurity -0.73 (-1.47 to 0.02) -0.80 (-1.49 to -0.11) -0.76 (-1.48 to -0.03) -1.26 (-1.87 to -0.64) <0.001 
Severe insecurity -0.91 (-1.72 to -0.10) -1.30 (-2.05 to -0.55) -2.17 (-2.96 to -1.38) -1.65 (-2.33 to -0.98)  
Undernutrition2 No      
Yes -0.28 (-1.00 to 0.44) -0.69 (-1.36 to -0.02) -0.00 (-0.70 to 0.70) -0.45 (-1.05 to 0.15) 0.212 
Inflammation No: CRP <5 g/l      
Yes: CRP 5+ g/l -1.17 (-2.06 to -0.28) -1.14 (-1.96 to -0.31) -1.15 (-2.02 to -0.28) -0.79 (-1.53 to -0.05)  
Hand grip strength 0.06 (0.03 to 0.10) 0.02 (-0.01 to 0.05) 0.02 (-0.02 to 0.05) 0.01 (-0.02 to 0.04) 0.024 
Phase of treatment Intensive      
Continuation 0.95 (0.33 to 1.58) 0.59 (0.01 to 1.17) 0.02 (-0.59 to 0.63) 0.08 (-0.44 to 0.59) 0.010 
TB treatment 
category 
Category 1      
Category 2 -0.38 (-0.96 to 0.20) -0.34 (-0.88 to 0.20) -0.56 (-1.13 to 0.01) 0.09 (-0.40 to 0.57) 0.027 
Current treatment 
side effects 
No      
Yes 0.33 (-0.34 to 1.01) 0.36 (-0.27 to 0.98) 0.24 (-0.42 to 0.90) 0.41 (-0.15 to 0.97) 0.709 
Ability to work 
affected 
No      
Yes -0.53 (-1.09 to 0.03) -0.66 (-1.19 to -0.14) -0.57 (-1.12 to -0.02) -0.29 (-0.76 to 0.18) 0.063 
Number of days adherent in last 7 days 0.06 (-0.05 to 0.16) 0.03 (-0.07 to 0.13) 0.06 (-0.05 to 0.16) 0.09 (0.00 to 0.18) 0.246 
Positive HIV test 
result 
No      
Yes -0.07 (-0.88 to 0.74) -0.49 (-1.25 to 0.26) -0.12 (-0.91 to 0.67) 0.51 (-0.16 to 1.19) 0.014 
Based on N=225 after further exclusion of Negros participants and additional missing values from persons attending clinics in Manilla (Negros m=137, HIV m=30).  
Bold type indicates 95% CIs excluding the null effect.  
1 global p-value from multivariable multivariate linear regression 
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2 Moderate/severe: BMI≥17kg/m2, Mild/normal: BMI<17kg/m2  
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Figure 1: Distribution of health-related quality of life domain scores in persons on drug-sensitive TB 
treatment regimens 
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Figure 2A: Adjusted effects on health-related quality of life domain scores in persons on drug-sensitive TB 
treatment regimens 
 
Undernutrition: Moderate/severe: BMI≥17kg/m2 compared to Mild/normal: BMI<17kg/m2  
Moderate and severe household food insecurity compared to mild/no insecurity 
Inflammation: C-reactive protein (CRP)>=5g/L compared to CRP<5g/L 
Category II compared to category I TB treatment regimen (Category II includes daily streptomycin injections in the 
intensive phase) 
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Figure 2B: Adjusted effects on health-related quality of life domain scores in persons on drug-sensitive TB 
treatment regimens registered in clinics in Metro Manilla with known HIV status 
 
Undernutrition: Moderate/severe: BMI≥17kg/m2 compared to Mild/normal: BMI<17kg/m2  
Moderate and severe household food insecurity compared to mild/no insecurity 
Inflammation: C-reactive protein (CRP)>=5g/L compared to CRP<5g/L 
Category II compared to category I TB treatment regimen (Category II includes daily streptomycin injections in the 
intensive phase) 
 
 
 
 
 
